Risk factors and associated problems in the management of infections with methicillin resistant Staphylococcus aureus

Indian Journal of Medical Microbiology

Volumn 24, Issue 3, 2006, Pages 182-185

  Srinivasan, S ^a   Sheela, D ^a   Shashikala, ^a   Mathew, R ^a   Bazroy, J ^a   Kanungo, R ^a  

^a PONDICHERRY INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Hospital acquired infection; MRSA; Multidrug resistance

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; CLINDAMYCIN; LINEZOLID; OFLOXACIN; RIFAMPICIN; VANCOMYCIN;

ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; EMERGENCY; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MANAGEMENT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MORBIDITY; POSTOPERATIVE PERIOD; RISK FACTOR;

EID: 33748141514     PISSN: 02550857     EISSN: 02550857     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mehta AP, Rodrigues C, Sheth K, Jani S, Hakimiyan A, Fazalbhoy N. Control of Methicillin Resistant Staphylococcus aureus in a tertiary care centre-A five year study. Indian J Med Microbiol 1998;16:31-4.
2. Salaria M, Singh M. Methicillin Resistant Staphylococcus aureus. Indian Pediatr 2001;38:29-34.
3. th ed. Albert Balows, Brian I Duerden Editors. Arnold: London; 1998. p. 602.
4. Fluit AC, Wielders CL, Verhoef J, Schmitz FJ. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European sentry study. J Clin Microbiol 2001;39:3727-32.
5. Perez-Roth E, Lorenzo-Diaz F, Batista N, Moreno A, Alvarez SM. Tracking Methicillin Resistant Staphylococcus aureus clones during a 5 year period (1998-2002) in a Spanish hospital. J Clin Microbiol 2004;42:4649-56.
6. Choudhary U, Anupama. Prevalence of Methicillin Resistant Staphylococcus aureus. Indian J Med Microbiol 1999;17:154-5.
7. th ed. The CV Mosby Co: St. Louis; 1994. p. 25.
8. Anupurba S, Sen MR, Nath G, Sharma BM, Gulati AK, Mohapatra TM. Prevalence of Methicillin Resistant Staphylococcus aureus in a tertiary care referral hospital in Eastern Uttar Pradesh. Indian J Med Microbiol 2003;21:49-51.
9. Krishna PS, Arora VM, Parthasarathy P, Datta P, Sharma VK. Increasing antimicrobial resistance among clinical isolates of Methicillin resistant Staphylococcus aureus (MRSA) from a Delhi hospital. J Academy Clin Microbiolog 2002;4:61-5.
10. Horvat RT, Klutman NE, Lacy MK, Grauer D, Wilson M. Effect of duplicate isolates of Methicillin-susceptible and Methicillin resistant Staphylococcus aureus on antibiogram data. J Clin Microbiol 2003;41:4611-6.
11. Fang H, Hedin G. Rapid screening and identification of Methicillin Resistant Staphylococcus aureus from clinical samples by selective broth & Real time PCR assay. J Clin Microbiol 2003;41:2894-9.
12. th ed. Kasper, Braunwald, Fauci, Hauser, Longo, Jameson, editors. Mc Graw-Hill Medical Publishing House: New York; 2005. p. 821-2.
13. Vidhani S, Mehndiratta PL, Mathur MD. Study of Methicillin Resistant Staphylococcus aureus (MRSA) isolates from high risk patients. Indian J Med Microbiol 2001;19:87-90.
14. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, et al. Infections with Vancomycin resistant Staphylococcus aureus containing the VanA resistance gene. New Eng J Med 2003;348:1342-7.
15. Cha R, Brown WJ, Rybak MJ. Bactericidal activities of Daptomycin, Quinopristin-Dalfopristin and Linezolid against Vancomycin resistant Staphylococcus aureus in an invitro pharmacodynamic model with simulated endocardial vegetation. J Antimicrob Chemother 2003;47:3960-3.
16. Centers for Disease Control and Prevention (CDC). Vancomycin-resistant Staphylococcus aureus. New York, 2004. Morb Mortal Wkly Rep 2004;53:322-3.
17. Gunderson BW, Ibrahim KH, Peloquin CA, Hovde LB, Rotschafer JC. Comparison of Linezolid activities against Methicillin Resistant Staphylococcus aureus and Vancomycin resistant Enterococccus faecium. J Antimicrob Chemother 2003;47:398-9.
18. Sweeney MT, Zurenko GE. In vitro activities of Linezolid combined with other antimicrobial agents against Staphylococci, Enterococci, Pneumococci and selected gram negative organisms. J Antimicrob chemother 2003;47:1902-6.
19. Assadulah S, Kakru DK, Thoker MA, Bhat FA, Hussain N, Shah A. Emergence of low level Vancomycin resistance in MRSA. Indian J Med Microbiol 2003;21:196-8.
20. Van Griethuysen A, Van 't Veen A, Buiting A, Walsh T, Kluytmans J. High percentage of Methicillin Resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides in the Netherlands. J Clin Microbiol 2003;41:2487-91.